Everolimus with paclitaxel and carboplatin as first-line treatment for metastatic large-cell neuroendocrine lung carcinoma: a multicenter phase II trial

AbstractBackground. Large-cell neuroendocrine carcinoma of the lung (LCNEC) is a rare disease with poor prognosis and limited treatment options. Neuroendocrine

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Christopoulos, Petros (VerfasserIn) , Thomas, Michael (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 23 May 2017
In: Annals of oncology
Year: 2017, Jahrgang: 28, Heft: 8, Pages: 1898-1902
ISSN:1569-8041
DOI:10.1093/annonc/mdx268
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1093/annonc/mdx268
Verlag, Volltext: https://academic.oup.com/annonc/article/28/8/1898/3848908
Volltext
Verfasserangaben:P. Christopoulos, W. Engel-Riedel, C. Grohé, C. Kropf-Sanchen, J. von Pawel, S. Gütz, J. Kollmeier, W. Eberhardt, D. Ukena, V. Baum, I. Nimmrich, C. Sieder, P. A. Schnabel, M. Serke & M. Thomas

MARC

LEADER 00000caa a2200000 c 4500
001 1577788206
003 DE-627
005 20230426230718.0
007 cr uuu---uuuuu
008 180720s2017 xx |||||o 00| ||eng c
024 7 |a 10.1093/annonc/mdx268  |2 doi 
035 |a (DE-627)1577788206 
035 |a (DE-576)507788206 
035 |a (DE-599)BSZ507788206 
035 |a (OCoLC)1341013739 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Christopoulos, Petros  |d 1977-  |e VerfasserIn  |0 (DE-588)138659702  |0 (DE-627)604886756  |0 (DE-576)308488067  |4 aut 
245 1 0 |a Everolimus with paclitaxel and carboplatin as first-line treatment for metastatic large-cell neuroendocrine lung carcinoma  |b a multicenter phase II trial  |c P. Christopoulos, W. Engel-Riedel, C. Grohé, C. Kropf-Sanchen, J. von Pawel, S. Gütz, J. Kollmeier, W. Eberhardt, D. Ukena, V. Baum, I. Nimmrich, C. Sieder, P. A. Schnabel, M. Serke & M. Thomas 
264 1 |c 23 May 2017 
300 |a 5 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 20.07.2018 
520 |a AbstractBackground. Large-cell neuroendocrine carcinoma of the lung (LCNEC) is a rare disease with poor prognosis and limited treatment options. Neuroendocrine 
700 1 |a Thomas, Michael  |e VerfasserIn  |0 (DE-588)1054438781  |0 (DE-627)79152213X  |0 (DE-576)41027089X  |4 aut 
773 0 8 |i Enthalten in  |t Annals of oncology  |d Amsterdam [u.a.] : Elsevier, 1990  |g 28(2017), 8, Seite 1898-1902  |h Online-Ressource  |w (DE-627)320428796  |w (DE-600)2003498-2  |w (DE-576)098134345  |x 1569-8041  |7 nnas  |a Everolimus with paclitaxel and carboplatin as first-line treatment for metastatic large-cell neuroendocrine lung carcinoma a multicenter phase II trial 
773 1 8 |g volume:28  |g year:2017  |g number:8  |g pages:1898-1902  |g extent:5  |a Everolimus with paclitaxel and carboplatin as first-line treatment for metastatic large-cell neuroendocrine lung carcinoma a multicenter phase II trial 
856 4 0 |u http://dx.doi.org/10.1093/annonc/mdx268  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://academic.oup.com/annonc/article/28/8/1898/3848908  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180720 
993 |a Article 
994 |a 2017 
998 |g 1054438781  |a Thomas, Michael  |m 1054438781:Thomas, Michael  |d 910000  |d 950000  |d 950900  |e 910000PT1054438781  |e 950000PT1054438781  |e 950900PT1054438781  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |p 7 
998 |g 138659702  |a Christopoulos, Petros  |m 138659702:Christopoulos, Petros  |d 910000  |d 950000  |d 950900  |e 910000PC138659702  |e 950000PC138659702  |e 950900PC138659702  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |p 1  |x j 
999 |a KXP-PPN1577788206  |e 301839559X 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"subtitle":"a multicenter phase II trial","title":"Everolimus with paclitaxel and carboplatin as first-line treatment for metastatic large-cell neuroendocrine lung carcinoma","title_sort":"Everolimus with paclitaxel and carboplatin as first-line treatment for metastatic large-cell neuroendocrine lung carcinoma"}],"recId":"1577788206","physDesc":[{"extent":"5 S."}],"relHost":[{"recId":"320428796","origin":[{"publisherPlace":"Amsterdam [u.a.] ; Dordrecht [u.a.] ; Oxford","dateIssuedDisp":"1990-","publisher":"Elsevier ; Kluwer ; Oxford Univ. Press","dateIssuedKey":"1990"}],"corporate":[{"role":"isb","display":"European Society for Medical Oncology"}],"note":["Gesehen am 12.11.20","Ungezählte Beil.: Supplement"],"part":{"issue":"8","text":"28(2017), 8, Seite 1898-1902","year":"2017","extent":"5","pages":"1898-1902","volume":"28"},"title":[{"subtitle":"official journal of the European Society for Medical Oncology","title":"Annals of oncology","title_sort":"Annals of oncology"}],"pubHistory":["1.1990 -"],"physDesc":[{"extent":"Online-Ressource"}],"disp":"Everolimus with paclitaxel and carboplatin as first-line treatment for metastatic large-cell neuroendocrine lung carcinoma a multicenter phase II trialAnnals of oncology","id":{"zdb":["2003498-2"],"issn":["1569-8041"],"eki":["320428796"]},"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"}}],"name":{"displayForm":["P. Christopoulos, W. Engel-Riedel, C. Grohé, C. Kropf-Sanchen, J. von Pawel, S. Gütz, J. Kollmeier, W. Eberhardt, D. Ukena, V. Baum, I. Nimmrich, C. Sieder, P. A. Schnabel, M. Serke & M. Thomas"]},"origin":[{"dateIssuedDisp":"23 May 2017","dateIssuedKey":"2017"}],"id":{"doi":["10.1093/annonc/mdx268"],"eki":["1577788206"]},"note":["Gesehen am 20.07.2018"],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"role":"aut","display":"Christopoulos, Petros","family":"Christopoulos","given":"Petros"},{"display":"Thomas, Michael","role":"aut","family":"Thomas","given":"Michael"}]} 
SRT |a CHRISTOPOUEVEROLIMUS2320